Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2026-03-27 @ 8:29 AM
Study NCT ID:
NCT06663059
Status:
RECRUITING
Last Update Posted:
2024-10-29
First Post:
2024-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
Sponsor:
Tang-Du Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT20240709
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None